Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Moshe Phillip

Showing results (291-300 of 334) with videos related to

Pageof 34
Sort By:
Pediatric Diabetes|April 30, 2025
Detection of Islet Autoantibodies in Whole Blood by Antibody Detection by Agglutination-PCR (ADAP) Technology Is Sensitive and Suitable for General Population Screening ProgramsTal Oron, Felipe de Jesus Cortez, Biana Shtaif, et al.
Pediatric Diabetes|November 27, 2021
Clinical characteristics, growth patterns, and long-term diabetes complications of 24 patients with neonatal diabetes mellitus: A single center experienceMarie Mouler, Yael Lebenthal, Liat de Vries, et al.
Diabetes, Obesity & Metabolism|November 20, 2020
Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream studyTorben Biester, Ido Muller, Thekla von dem Berge, et al.
Diabetes, Obesity & Metabolism|December 17, 2016
MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trialRevital Nimri, Natasa Bratina, Olga Kordonouri, et al.
Pediatric Diabetes|June 16, 2015
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitusMarianna Rachmiel, Pnina Strauss, Nitzan Dror, et al.
Diabetes, Obesity & Metabolism|November 4, 2020
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studiesMoshe Phillip, Chantal Mathieu, Marcus Lind, et al.
Hormone Research in Paediatrics|June 1, 2026
Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and EfficacyRenata Stawerska, John Choe, Ronnie Wang, et al.
Diabetes Care|October 3, 2019
Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover TrialKlemen Dovc, Claudia Piona, Gül Yeşiltepe Mutlu, et al.
Diabetes Technology & Therapeutics|September 9, 2020
The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies IntroductionMoshe Phillip, Richard M Bergenstal, Kelly L Close, et al.
Diabetes Technology & Therapeutics|April 1, 2022
A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670GStuart A Weinzimer, Ryan J Bailey, Richard M Bergenstal, et al.
Pageof 34

Showing results (291-300 of 334) with videos related to

Sort By:
Pageof 34
Pediatric Diabetes|April 30, 2025
Detection of Islet Autoantibodies in Whole Blood by Antibody Detection by Agglutination-PCR (ADAP) Technology Is Sensitive and Suitable for General Population Screening ProgramsTal Oron, Felipe de Jesus Cortez, Biana Shtaif, et al.
Pediatric Diabetes|November 27, 2021
Clinical characteristics, growth patterns, and long-term diabetes complications of 24 patients with neonatal diabetes mellitus: A single center experienceMarie Mouler, Yael Lebenthal, Liat de Vries, et al.
Diabetes, Obesity & Metabolism|November 20, 2020
Add-on therapy with dapagliflozin under full closed loop control improves time in range in adolescents and young adults with type 1 diabetes: The DAPADream studyTorben Biester, Ido Muller, Thekla von dem Berge, et al.
Diabetes, Obesity & Metabolism|December 17, 2016
MD-Logic overnight type 1 diabetes control in home settings: A multicentre, multinational, single blind randomized trialRevital Nimri, Natasa Bratina, Olga Kordonouri, et al.
Pediatric Diabetes|June 16, 2015
Alpha-1 antitrypsin therapy is safe and well tolerated in children and adolescents with recent onset type 1 diabetes mellitusMarianna Rachmiel, Pnina Strauss, Nitzan Dror, et al.
Diabetes, Obesity & Metabolism|November 4, 2020
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studiesMoshe Phillip, Chantal Mathieu, Marcus Lind, et al.
Hormone Research in Paediatrics|June 1, 2026
Extension of the Phase 3 Trial of Somatrogon in Children with Growth Hormone Deficiency: 3 Years of Safety and EfficacyRenata Stawerska, John Choe, Ronnie Wang, et al.
Diabetes Care|October 3, 2019
Faster Compared With Standard Insulin Aspart During Day-and-Night Fully Closed-Loop Insulin Therapy in Type 1 Diabetes: A Double-Blind Randomized Crossover TrialKlemen Dovc, Claudia Piona, Gül Yeşiltepe Mutlu, et al.
Diabetes Technology & Therapeutics|September 9, 2020
The Digital/Virtual Diabetes Clinic: The Future Is Now-Recommendations from an International Panel on Diabetes Digital Technologies IntroductionMoshe Phillip, Richard M Bergenstal, Kelly L Close, et al.
Diabetes Technology & Therapeutics|April 1, 2022
A Comparison of Postprandial Glucose Control in the Medtronic Advanced Hybrid Closed-Loop System Versus 670GStuart A Weinzimer, Ryan J Bailey, Richard M Bergenstal, et al.
Pageof 34